(Q34395306)

English

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Mark Lunt

3

0 references

Kimme L. Hyrich

1

object named as

Kimme L Hyrich

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Deborah P.M. Symmons

4

object named as

Deborah P M Symmons

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Kath D Watson

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

British Society for Rheumatology Biologics Register (BSRBR)

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

29 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

117-123

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Changing patterns of tumor necrosis factor inhibitor use in 9074 patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Long term safety of etanercept in elderly subjects with rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999956

6 July 2018

Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

The burden of rheumatoid arthritis and access to treatment: uptake of new therapies

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatolo

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

The British Society for Rheumatology Biologics Register: 6 years on

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ209

21 January 2018

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20671021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/RHEUMATOLOGY/KEQ209

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34395306&oldid=1991885415"